🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/01/2021 | 77,01 | 77,47 | 76,39 | 77,43 | +0,21% | 1,40% | 9.957.677 |
| 22/01/2021 | 77,19 | 77,70 | 77,06 | 77,27 | -0,25% | 0,83% | 9.436.926 |
| 21/01/2021 | 78,06 | 78,53 | 77,25 | 77,46 | -1,55% | 1,64% | 9.043.716 |
| 20/01/2021 | 79,44 | 79,72 | 78,50 | 78,68 | -0,88% | 1,54% | 11.097.901 |
| 19/01/2021 | 79,74 | 80,06 | 78,87 | 79,38 | -0,23% | 1,48% | 8.467.316 |
| 15/01/2021 | 78,09 | 79,68 | 77,82 | 79,56 | +1,47% | 2,37% | 10.203.538 |
| 14/01/2021 | 78,65 | 79,01 | 78,13 | 78,41 | -0,21% | 1,12% | 11.366.398 |
| 13/01/2021 | 79,55 | 79,55 | 78,45 | 78,57 | -0,90% | 1,38% | 10.093.812 |
| 12/01/2021 | 81,22 | 81,24 | 78,77 | 79,28 | -2,25% | 3,04% | 10.128.606 |
| 11/01/2021 | 79,68 | 81,68 | 79,44 | 81,11 | +2,37% | 2,81% | 13.488.179 |
| 08/01/2021 | 80,51 | 80,51 | 78,77 | 79,23 | -1,18% | 2,16% | 9.563.105 |
| 07/01/2021 | 78,77 | 80,51 | 78,31 | 80,17 | +1,99% | 2,79% | 10.447.931 |
| 06/01/2021 | 76,89 | 78,95 | 76,63 | 78,61 | +1,58% | 3,02% | 10.521.396 |
| 05/01/2021 | 76,98 | 77,67 | 76,25 | 77,39 | +0,17% | 1,85% | 10.956.526 |
| 04/01/2021 | 78,24 | 78,33 | 76,22 | 77,25 | -1,03% | 2,70% | 10.502.637 |
| 31/12/2020 | 76,95 | 78,19 | 76,70 | 78,05 | +1,50% | 1,93% | 5.511.118 |
| 30/12/2020 | 77,92 | 77,99 | 76,85 | 76,90 | -1,02% | 1,46% | 5.933.357 |
| 29/12/2020 | 77,10 | 77,85 | 77,06 | 77,69 | +1,21% | 1,03% | 5.708.037 |
| 28/12/2020 | 76,96 | 77,42 | 76,46 | 76,77 | +0,39% | 1,25% | 4.804.242 |
| 24/12/2020 | 76,34 | 76,75 | 76,21 | 76,47 | +0,48% | 0,70% | 2.957.456 |
| 23/12/2020 | 75,94 | 76,75 | 75,93 | 76,11 | +0,43% | 1,08% | 6.056.078 |
| 22/12/2020 | 75,37 | 76,33 | 74,66 | 75,78 | +0,16% | 2,22% | 9.052.414 |
| 21/12/2020 | 75,19 | 75,70 | 74,18 | 75,66 | -0,30% | 2,02% | 11.140.764 |
| 18/12/2020 | 76,06 | 76,51 | 74,86 | 75,89 | -0,36% | 2,17% | 33.161.759 |
| 17/12/2020 | 76,71 | 76,87 | 76,03 | 76,16 | -0,01% | 1,09% | 11.710.038 |
| 16/12/2020 | 76,60 | 77,05 | 76,00 | 76,17 | -0,81% | 1,37% | 9.487.649 |
| 15/12/2020 | 76,81 | 77,33 | 76,34 | 76,79 | +0,20% | 1,29% | 10.087.838 |
| 14/12/2020 | 78,85 | 79,27 | 76,37 | 76,64 | -3,18% | 3,68% | 13.139.300 |
| 11/12/2020 | 79,06 | 79,60 | 78,74 | 79,16 | -0,04% | 1,09% | 7.979.158 |
| 10/12/2020 | 79,83 | 80,10 | 78,93 | 79,19 | -0,58% | 1,46% | 7.349.205 |